Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-06-10 21:49:45 ET · period of report 2026-06-08 · accession 0001193125-26-266437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 21:49 | 2026-06-08 | AXSM | JEFFS ROGER | Dir | M - OptEx | — | +1,429 | 58.9K | +2% | — |
| D | 2026-06-10 21:49 | 2026-06-08 | AXSM | JEFFS ROGER | Dir | M - OptEx | $0.00 | -1,429 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-08 | M | A | 1,429 | — | 58,939 | D | — | — | (F1) On June 6, 2025, the Reporting Person was granted 1,429 RSUs, all of which vested upon the one-year anniversary of the date of grant. (F2) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2026-06-08 | M | D | 1,429 | $0.00 | 0 | D | — · — to — | 1,429 Common Stock | (F2) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F2) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F2) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |